95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.28%
Negative revenue growth while AEM stands at 14.68%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-17.67%
Negative gross profit growth while AEM is at 11.57%. Joel Greenblatt would examine cost competitiveness or demand decline.
-6.08%
Negative EBIT growth while AEM is at 20.30%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-6.08%
Negative operating income growth while AEM is at 20.30%. Joel Greenblatt would press for urgent turnaround measures.
30.00%
Net income growth 1.25-1.5x AEM's 21.03%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
75.00%
EPS growth above 1.5x AEM's 14.06%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
75.00%
Diluted EPS growth above 1.5x AEM's 12.70%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.40%
Share reduction more than 1.5x AEM's 6.73%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.45%
Diluted share reduction more than 1.5x AEM's 6.73%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
5.22%
Positive OCF growth while AEM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
5.22%
Positive FCF growth while AEM is negative. John Neff would see a strong competitive edge in net cash generation.
210.94%
10Y revenue/share CAGR under 50% of AEM's 747.21%. Michael Burry would suspect a lasting competitive disadvantage.
149.23%
5Y revenue/share CAGR at 50-75% of AEM's 251.76%. Martin Whitman would worry about a lagging mid-term growth trajectory.
51.45%
3Y revenue/share CAGR under 50% of AEM's 184.98%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
1261.50%
10Y OCF/share CAGR at 50-75% of AEM's 1816.75%. Martin Whitman might fear a structural deficiency in operational efficiency.
330.54%
5Y OCF/share CAGR at 50-75% of AEM's 627.69%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
67.97%
3Y OCF/share CAGR under 50% of AEM's 154.09%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
No Data
No Data available this quarter, please select a different quarter.
426.93%
Below 50% of AEM's 2954.90%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
133.14%
Below 50% of AEM's 758.24%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
1497.53%
10Y equity/share CAGR above 1.5x AEM's 810.90%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
453.49%
5Y equity/share CAGR above 1.5x AEM's 265.91%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
68.14%
3Y equity/share CAGR 1.25-1.5x AEM's 54.44%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.44%
Firm’s AR is declining while AEM shows 28.24%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-0.67%
Negative asset growth while AEM invests at 22.63%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
6.55%
Under 50% of AEM's 14.82%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-5.88%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-19.14%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.